What is CAH's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 58.57B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CAH?

P/E (TTM) is 33.84 and 52-week range is $180.45 to $259.84 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CAH figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for CAH?

The company profile lists revenue (TTM) near $251.60B, net income (TTM) near $168.57B, EPS (TTM) near $7.24 when available from the market-data feed. Figures are informational and may lag live markets.

Does CAH show a dividend on Chartloom?

The overview lists dividend per share (TTM) near $2.08, yield near 0.85%, ex-dividend date Oct 1, 2026 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is Cardinal Health, Inc. based, and what identifiers does Chartloom list?

The company context section lists headquarters in Dublin Ohio, Ohio, US, 231.6M shares outstanding, ISIN US14149Y1082 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Cardinal Health, Inc.

$CAH

Health Care · Health Care Providers & Services

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 63,900 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. The company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

Employees

63,900

Website

www.cardinalhealth.com/en.html

IPO

1983-08-04

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NEW YORK STOCK EXCHANGE, INC.

ISIN

US14149Y1082

Headquarters

Dublin Ohio, Ohio, US

Shares outstanding

231.6M

NAICS sector

Wholesale Trade

Institutional ownership

90.63%

Browse other companiesFree AI scores and summaries for more stocks